[1]邹钢,胡晓蓉,李翠吟,等.妊娠糖尿病患者超敏C反应蛋白动态变化与胰岛素抵抗的关系[J].国际放射医学核医学杂志,2008,32(4):232-235.
　ZOU Gang,HU Xiao-rong,LI Cui-yin,et al.Alteration of serum high-sensitivity C-reactive protein level in gestational diabetes mellitus and correlation with in insulin resistance[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):232-235.
点击复制

妊娠糖尿病患者超敏C反应蛋白动态变化与胰岛素抵抗的关系(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
32
期数:
2008年第4期
页码:
232-235
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Alteration of serum high-sensitivity C-reactive protein level in gestational diabetes mellitus and correlation with in insulin resistance
作者:
邹钢1;  胡晓蓉2;  李翠吟1;  邵豪1;  陆泽元1;  赖丽萍1;  柳岚1;  马江涛3
1. 518033 深圳, 深圳市福田人民医院内分泌科;
2. 518033 深圳, 深圳市福田人民医院妇产科;
3. 518020 深圳, 深圳市人民医院检验医学部
Author(s):
ZOU Gang1;  HU Xiao-rong2;  LI Cui-yin1;  SHAO Hao1;  LU Ze-yuan1;  LAI Li-ping1;  LIU Lan1;  MA Jiang-tao3
1. Department of Endocrinology, The Futian People’s Hospital, Shenzhen 518033, China;
2. Department of Gastroenterology, The Futian People’s Hospital, Shenzhen 518033, China;
3. Department of Laboratory, The Shenzhen People 0 Hospital, Shenzhen 5180
关键词:
妊娠糖尿病; C反应蛋白; 胰岛索抵抗
Keywords:
Gestational diabetes mellitus; C-reactive protein; Insulin resistance
摘要:
目的 探讨妊娠糖尿病患者超敏C反应蛋白(hs-CRP)动态变化与胰岛素抵抗(IR)的关系。方法 选择妊娠糖尿病(GDM)患者32例和正常糖耐量(NGT)孕妇3l例为研究对象,分别测定孕25~28周、孕29~32周、孕37~38周、产后6~8周空腹血清hs-CRP、空腹胰岛素(FINS)、空腹血糖(FBG)水平,采用放射免疫法测定FINS,葡萄糖氧化酶法测定FBG,免疫散射比浊法测定hs-CRP,以HOMA胰岛索抵抗指数(HOMA-IR)评价IR。结果 (1) GDM组和NGT组血清hs-CRP水平在妊娠各阶段(孕25~28周、孕29~32周、孕37~38周)的变化不明显,但均显著高于产后;(2) GDM组妊娠各阶段血清hs-CRP水平均高于NGT组(t值分别为7.31、7.78、6.33,P<0.01);(3) GDM组妊娠各阶段HOMA-IR均显著高于NGT组(t值分别为31.18、31.10、28.39,P<0.01);(4) Pearson相关分析显示。FBG、FINS、hs-CRP与HOMA-IR显著相关(相关系数分别为0.478、0.902、0.293,P<0.01),多元回归分析提示,FINS、FBG、hs-CRP是影响HOMA-IR的显著因素(回归系数分别为0.441、0.876、0.261,P<0.01)。结论 GDM患者血清hs-CRP水平在妊娠的不问阶段变化不明显,但显著高于NGT组,且与HOMA-IR显著相关。
Abstract:
Objective To explore the dynamic of high-sensitivity C-reactive protein (hs-CRP) and its correlation with insulin resistance (IR) during different stages of gestational diabetes mellitus (GDM). Methods Thirty-two subjects with GDM and thirty-one cases of normal glucose tolerance (NGT) pregnant women were enrolled in the study,fasting insulin (FINS) were determined by radioimmunoassay,the fasting blood glucose (FBG) was measured by using glucose oxidase,immunoturbidimetry performed to evaluate serum hs-CRP levels.Tests repeated for each group according different stages of prenatal 25-28 weeks,29-32 weeks,37-38 weeks and postpartum 6-8 weeks.IR was assessed by the homeostasis model assessment insulin resistance index (HOMA-IR),Results ①Serum hs-CRP levels in NGT and GDM had few change with gestational age,but both significantly decreased at postpartum.②Serum hs-CRP levels in GDM significantly increased than NGT in the same stage (t was 7.31,7.78,6.33,respectively,P<0.01).③HOMA-IR in GDM significantly increased than NGT in the same gestational stage (t was 31.18,31.10, 28.39,respectively,P<0.01).④Pearson correlation analysis showed that FBG,FINS and hs-CRP had significant association with HOMA-IR (regression coefficient of 0.478,0.902,0.293,respectively,P<0.01). Multiple regression analysis identified FINS,FBG and hs-CRP as the factors significantly affecting HOMA-IR (regression coefficient of 0.441,0.876,0.261,respectively,P<0.01).Conclusion Serum hs-CRP levels in GDM had few change with gestational age,but all significantly increased than NGT in the same stage,and which were the most significant factors affecting HOMA-IR.

参考文献/References:

[1] Garcia DM,Marks JE,Latifl HR el al.Childhood eerebellar astrocytomas:is there a role for postoperative irradiation?[J].Int J Radiat Oneol Biol Phys,1990,18(4):815-818.
[2] 陈智,李旭,张宇,等.脑恶性胶质瘤82例放射治疗疗效分析[J].中华放射医学与防护杂志,2006,26(4):410-410.
[3] 梅国顺,杜建新.脑恶性胶质瘤的局部治疗现状[J].中华神经外科疾病研究杂志,2007,4(6):379-381.
[4] Eyüpeoglu IY,Hahnen E,Buslei R,et al.Subereylanilide hydroxamie acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo[J].J Neurochem,2005,93(4):992-999.
[5] Nieholas A,Butowski,Patrieia K,et al.Diagnosis and treatment of recurrent higll-grade astrecytoma[J].J Clin Oncol,2006,24(8): 1273-1280.
[6] Kropacova k Slovinskn L,Misurova E.Cytogenetie changes in the liver of progeny of irradiated male rats[J].J Radia Res,2002,43(2): 125-133.
[7] Khmelevskii EV.Radiotherapy for recurrent breast cancer[J]. Voprosy Onkologii,2000,46(2):167-171.
[8] Pelevina II,Gotlib VIa,Kudriashova OV,et al.Properties of progeny of irradiated cells[J].Tsitologiia,1998,40(5):467-477.
[9] 刘树铮.适应性反应[J].中华放射医学与防护杂志,2000,20(6): 373-377.
[10] 姜桔红,王捷,余忠华,等.照射存活后代的鼻咽癌细胞株放射生物学特性研究[J].实用癌症杂志,2002,26(4):566-568.
[11] Graf R,Hildebrandt B,Tilly W.et al.Dose-escMated conformal radiotherapy of glioblastomas-results of a retrospective comparison applying radiation doses of 60 and 70 Gy[J].Onkologie,2005,28(6-7):325-330.
[12] Ulm AJ 3rd,Friedman WA,Bradshaw P.et al.Radiosurgery in the treatment of malignant gliomas:the University of Florida experience[J].Neurosurgery,2005,57(3):512-517.
[13] Cardinale R,Won M,Choucair A,et al.A phaseⅡ trial of accelerated radiotherapy using weekly stereotaetie conformal boost for supratentorial glioblastoma multiform:RTOG 0023[J].Int J Radiat Oncol Biol Phys,2006,65(5):1422-1428.
[14] Graf R,Hildebrandt B,Tilly W,et al.Dose-escalated confomud radiotherapy of glioblastomas-results of a retrospective comparison applying radiation doses of 60 and 70 Gy[J].Onkologle,2005,28(6-7):325-330.
[15] Stupp R,Mason WP,vtul den Bent MJ,et al.Radiotherapy plus concomitant and adjuvant temomlomide for glioblastonut[J].N Engl J Med,2005,352(10):987-996.
[16] Intergroup radiation therapy oncology group trial 9402.caimeross G,Berkey B,et al.Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglionm:Intergroup Radiation Therapy Oncology Group Trial 9402[J].J Clin Oncol,2006,24(18):2707-2714.
[17] van den Bent MJ,Carpentier AF,Brandes AA,et al.Adjuvant proearbazine,Iomustine,and vincristine improve progression-free survival but not overall survival in newly diagnosed anaplastic oligodendroglionms and oligoastroeytomas:a randomized European Organization for Research and Treatment of Cancer phase III trial[J].J Clin Onenl,2006,24(18):2715-2722.
[18] Anal S,Tanaka M,Shiveriek KT,et al.Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenoearcinoma cells[J].J Urol,2007,177(5):1913-1917.
[19] Nakano Y,Kuroda E,Kito T.et al.Induction of macrophagie prostaglandin E2 synthesis by glioma cells[J].J Neurosurg, 2006.104(4):574-582.
[20] Reardon DA,Quinn JA,Vredenburgh J,el al.Phase Ⅱ trial of irinotecan plus celecoxib in adults with recurrent malignant glioma[J].Cancer,2005,103(2):329-338.

备注/Memo

备注/Memo:
收稿日期:2008-03-21。
基金项目:深圳市科技计划项目(卫生医疗类)(200803145)
通讯作者:邹钢,E-mail:zhenjin1969@yahoo.com.cn
更新日期/Last Update: 1900-01-01